BlackRock’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.1M Buy
4,061,996
+506,448
+14% +$6.4M ﹤0.01% 2577
2025
Q4
$59M Buy
3,555,548
+153,224
+5% +$2.19M ﹤0.01% 2420
2025
Q3
$40M Buy
3,402,324
+86,976
+3% +$898K ﹤0.01% 2639
2025
Q2
$31.8M Sell
3,315,348
-8,255
-0.2% -$45.7K ﹤0.01% 2755
2025
Q1
$20.8M Sell
3,323,603
-178,772
-5% -$1.09M ﹤0.01% 2914
2024
Q4
$28.4M Buy
3,502,375
+379,805
+12% +$4.7M ﹤0.01% 2819
2024
Q3
$56.5M Buy
3,122,570
+196,197
+7% +$2.74M ﹤0.01% 2402
2024
Q2
$30.1M Buy
2,926,373
+180,993
+7% +$1.86M ﹤0.01% 2732
2024
Q1
$29.2M Buy
2,745,380
+66,489
+2% +$565K ﹤0.01% 2774
2023
Q4
$24.5M Buy
2,678,891
+241,149
+10% +$2.08M ﹤0.01% 2898
2023
Q3
$25.3M Buy
2,437,742
+435,110
+22% +$5.97M ﹤0.01% 2804
2023
Q2
$28.7M Buy
2,002,632
+369,722
+23% +$4.26M ﹤0.01% 2807
2023
Q1
$11.7M Sell
1,632,910
-61,521
-4% -$540K ﹤0.01% 3237
2022
Q4
$19M Buy
1,694,431
+151,281
+10% +$1.56M ﹤0.01% 3062
2022
Q3
$17.1M Sell
1,543,150
-34,587
-2% -$330K ﹤0.01% 3121
2022
Q2
$13.3M Buy
1,577,737
+199,220
+14% +$2.05M ﹤0.01% 3344
2022
Q1
$18.8M Sell
1,378,517
-94,608
-6% -$1.53M ﹤0.01% 3209
2021
Q4
$29M Buy
1,473,125
+290,247
+25% +$6.83M ﹤0.01% 3035
2021
Q3
$38M Buy
1,182,878
+22,441
+2% +$746K ﹤0.01% 2845
2021
Q2
$39.3M Buy
1,160,437
+344,497
+42% +$12.3M ﹤0.01% 2853
2021
Q1
$30.6M Buy
815,940
+25,060
+3% +$1.05M ﹤0.01% 2936
2020
Q4
$26.3M Buy
790,880
+73,968
+10% +$3M ﹤0.01% 2870
2020
Q3
$26.3M Sell
716,912
-9,015
-1% -$312K ﹤0.01% 2704
2020
Q2
$23.9M Buy
725,927
+140,981
+24% +$5.42M ﹤0.01% 2707
2020
Q1
$15.1M Sell
584,946
-55,769
-9% -$1.86M ﹤0.01% 2758
2019
Q4
$20M Buy
+640,715
New +$16.1M ﹤0.01% 2885

Other funds holding PHAT